Intra-Cellular Therapies Inc. buy RudolfL
Start price
25.01.22
/
60%
€40.53
Target price
30.01.23
€65.00
Performance (%)
10.09%
End price
20.01.23
€44.62
Summary
This prediction ended on 20.01.23 with a price of €44.62. The prediction had a final performance of 10.09%. RudolfL has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | -6,02 % | -4,60 % | 1,27 % | 48,62 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % | 14,57 % | 86,13 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % | 28,11 % | 53,17 % |
| iShares S&P 500 | -0,26 % | -0,84 % | 10,20 % | 58,40 % |
Comments by RudolfL for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Kursziel geändert auf 65,0